Our study, as well as Norman et al.’s results [44,45], have demonstrated that anti-KLHL12 antibodies are novel, highly specific markers of PBC and, most importantly, they have been suggested to be promising new candidates in the clinical diagnosis of PBC. The gene discussed is KLHL12; the disease is primary biliary cholangitis.